| Nom du produit | Bunanselin |
|---|---|
| Numéro CAS | 132810-10-7 |
| Formule moléculaire | C₁₉H₂₁N₃O₄S |
| Poids moléculaire | 387.45 |
| Apparence | Poudre cristalline blanche à blanc cassé |
| Essai (HPLC) | ≥98% |
| Perte au séchage | ≤0.5% |
| Résidu au feu | ≤0.1% |
| Métaux lourds | ≤ 10 ppm |
| Point de fusion | 178-182°C |
Besoin d'aide ? Contacter notre équipe

Bunanselin, 132810-10-7, 3-(3,4-dimethoxyphenyl)-N-methyl-2-oxo-2H-chromene-7-carboxamide
Bunanselin is making its mark in the pharmaceutical intermediate space, and not just for its long name. It’s a coumarin derivative that’s drawing attention for its potential in medicinal chemistry — specifically as a building block for compounds targeting inflammatory and oxidative stress pathways. That’s the kind of versatility that gets formulators excited.
We supply Bunanselin as a high-purity crystalline powder, consistent from batch to batch. Whether you’re running a small-scale R&D trial or scaling up for commercial production, we’ve got the capacity to match.